Atopic Dermatitis — Is There a Vaccine? — What are the Types of Atopic Dermatitis?
The manifestations associated with Atopic Dermatitis These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "Atopic Dermatitis — Is There a Vaccine? — What are the Types of Atopic Dermatitis?"This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Atopic Dermatitis: Types, Treatments, and the Role of Vaccination
Atopic dermatitis is a chronic inflammatory skin condition that raises many questions for patients, especially regarding the recurrence of symptoms and available treatment options. Many people report that prescribed medications seem to lose their effect after a few days, causing flare-ups to return, particularly during periods of intense heat. To understand the best treatment method, the first step is to classify the disease according to its severity, which can be mild, moderate, or severe, as well as to assess whether the condition is acute or chronic.
In acute atopic dermatitis flare-ups, there is a large release of circulating histamine. In these cases, the use of antihistamines (anti-allergy medications) can help provide immediate relief from itching and initial control of the condition. On the other hand, in chronic atopic dermatitis—characterized by longer periods of evolution—the role of histamine is less significant. Persistent itching is usually triggered by activation of nerve endings in the skin, mediated by inflammatory substances such as interleukin-31. This molecule stimulates the inflammatory process in thin nerve fibers, making the use of conventional anti-allergy medications less effective. For these cases, management may involve specific medications that modulate nerve sensitization, such as drugs that act to block these pruritic stimuli.
Is there a vaccine for atopic dermatitis?
A common question is whether there is any type of vaccine to treat the condition. The answer is yes, allergen-specific immunotherapy (popularly known as allergy shots) can be used as part of the therapeutic strategy. However, this indication depends on a rigorous medical evaluation that proves the association between dermatitis and environmental allergens—such as dust mites and fungi—confirmed by allergy tests (such as the...). prick testThis can be diagnosed through blood tests to measure specific IgE levels. It is crucial to emphasize that a positive test result alone does not necessarily indicate a clinical allergy; sensitization must be directly related to the patient's symptoms.
Why is atopic dermatitis a multifactorial disease?
The treatment of atopic dermatitis goes far beyond controlling an isolated allergy. It is a complex and multifactorial pathology, influenced by several aspects:
- Genetic and hereditary component: Patients with atopy are often born with a drier skin barrier, associated with alterations in structural proteins (such as claudins) that reduce the skin's ability to retain water and protect itself.
- Local immunodeficiency and secondary infections: There is a natural tendency for the bacteria to proliferate. Staphylococcus aureus on the skin of atopic individuals. This microorganism produces toxins (superantigens) that intensify inflammation, worsen lesions, and significantly increase itching.
- Irritating and environmental factors: Exposure to chemicals, fabric softeners, strong-smelling substances in cosmetics, or household cleaning products can trigger or worsen seizures.
Due to this multitude of factors, there is no single "silver bullet" or magic solution capable of solving the problem in isolation. Specialized medical care requires a broad and eclectic approach.
Therapeutic innovations: Monoclonal antibodies
In addition to desensitizing vaccines for selected patients, modern medicine has made important advances for moderate to severe cases, such as monoclonal antibodies (for example, dupilumab). This is an immunobiological drug that acts by specifically blocking central inflammatory interleukins in the disease process (such as interleukin-4 and interleukin-13), providing a significant improvement in the quality of life of patients.
Important note: This content is strictly educational and informative in nature and should in no way replace consultation, diagnosis, and individualized evaluation with a specialist physician in Allergy and Immunology.
Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema
In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.
💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Skin Barrier Health, Immune Inflammation, and Pruritus Control
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.
Therapeutic Hydration, Skin Tests and Immunotherapy
The daily pillar of protection consists of immediate intensive hydration after quick, lukewarm showers with syndet cleansers (without alkaline soap), combined with personalized protocols of... vaccine for dermatitisIn causal investigation, the allergy test (whether it's a prick test for aeroallergens or a patch test for chemicals) guides precise avoidance measures and enables the indication of allergy vaccine in patients sensitized to dust mites.
IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances
In contemporary allergology, it is essential to differentiate the immunological reaction against food proteins—such as casein, alpha-lactalbumin, and beta-lactoglobulin in cow's milk, ovomucoid in eggs, or tropomyosin in crustaceans—from non-immune digestive intolerances, such as lactase enzyme deficiency. While intolerance causes abdominal distension, flatulence, and osmotic diarrhea restricted to the digestive tract, food allergy involves Th2 lymphocytes and IgE antibodies or eosinophilic cellular inflammation, and can cause acute urticaria, angioedema, bronchospasm, proctocolitis, or anaphylaxis within minutes of ingesting trace amounts.
Mast Cell Activation, Histamine, and the Bradykinin Pathway
When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.
Inflammation of the Respiratory Mucosa, House Mites, and Local Complications
The nose performs vital functions of filtering, warming, and humidifying inhaled air before it reaches the lungs. In allergic rhinitis and chronic rhinosinusitis, contact between aeroallergens—especially house dust mites (Dermatophagoides pteronyssinus and Blomia tropicalis), anemophilous fungi, and epithelia—and IgE antibodies fixed to mast cells in the nasal mucosa triggers the immediate release of histamine, leukotrienes, and prostaglandins. This process generates nasal obstruction, itching, sneezing fits, post-nasal drip (a frequent cause of chronic nighttime cough), and vascular fragility that can favor minor bleeding (epistaxis) due to trauma from blowing the nose or from poorly directed sprays.
Immediate Reactions, Delayed Drug Reactions, and Risks of Self-Medication
Another critical pharmacovigilance point concerns the indiscriminate use of long-acting oral or injectable systemic corticosteroids (such as intramuscular betamethasone combinations). Although they provide apparent rapid relief, repeated applications suppress the hypothalamic-pituitary-adrenal axis, raise blood pressure and blood glucose, demineralize bone mass, weaken immunity against infections, and can cause local neuropathic pain when improperly applied to the gluteal region.
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
Preventive immunization represents one of the greatest achievements of medicine in reducing hospitalizations and serious infectious complications, especially in patients with chronic respiratory diseases (such as asthma and COPD), heart disease, high blood pressure, and diabetes. Patients allergic to aeroallergens, foods, or common medications do not have a general contraindication to vaccines; allergological attention focuses on the specific evaluation of rare cases of previous anaphylaxis to isolated components of the formula (such as polyethylene glycol, polysorbate, or specific protein traces), situations that now have safe assisted application protocols.
Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E
Choosing the ideal immunobiological agent requires rigorous phenotyping and endotyping by a specialist physician, evaluating blood biomarkers (peripheral eosinophil count, serum levels of total IgE and exhaled fraction of nitric oxide) and coexisting comorbidities, such as severe asthma, nasal polyposis, refractory chronic spontaneous urticaria, and moderate to severe atopic dermatitis. Subcutaneous applications follow a regular schedule under safe clinical supervision.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond the direct physical manifestations, uncontrolled conditions linked to Atopic Dermatitis profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, reinforces the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being of the individual.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. For peaceful skin, free from constant itching and sleep-depriving flare-ups.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continued treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Atopic Dermatitis It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




